SUMMARY
informed of the study and signed a consent form at the preoperative visit.
In the first part, 13 patients received vecuronium 150 ug kg" 1 i.v. The concentrations of vecuronium in the plasma (n = 13) and in random bile samples obtained during surgery from the common bile duct (n = 11), as well as the amount of vecuronium in bile collected in the postoperative period through a T-drain (n = 6) were measured. In the second part of the study liver biopsies were randomly obtained from six other patients who underwent partial liver resection, at 5 (» = 3) or No patient with impairment of renal, metabolic or liver function was investigated. Likewise, patients receiving antibiotics or other drugs known to interfere with neuromuscular transmission were not admitted to the study. Operations which resulted in a blood loss of more than 20% of the patient's blood volume were not included in the study.
Anaesthetic regimen
Patients were premedicated with diazepam 10 mg by mouth or papaveretum 10 mg i.m. with or without atropine 0.5 mg i.m. Anaesthesia was induced with thiopentone 3-5 mg kg" 1 , and the trachea intubated after the administration of suxamethonium 0.75-1 mg kg" 1 i.v. Immediately after intubation, artificial ventilation was instituted with a mixture of 33% oxygen in nitrous oxide, and the minute volume was adjusted to maintain an end-tidal carbon dioxide tension of 4-6 kPa. Before any surgical intervention took place, anaesthesia was supplemented with the addition of 1 % halothane to the gas mixture. During surgery anaesthesia and analgesia were maintained with either 3% halothane alone (n = 4) or, if more analgesia was required, halothane 2% supplemented with fentanyl 0.2-0.6 mg (n = 9). Patients in part II of the study received gallamine triethiodide if muscle paralysis was required by the surgeons before the liver biopsy could be obtained. Gallamine does not interfere with the fluorimetric or chromatographic analysis of vecuronium (U. W. Kersten-Kleef, personal communication) , and is almost completely eliminated by the kidneys (Agoston et al., 1978) . 
Procedures: Part I
The procedure followed in part I of this study is presented in figure 1. Vecuronium was supplied as a lyophilized powdered preparation (4 mg ml" 1 per ampoule). A single dose of lSOugkg" 1 dissolved in saline 10 ml was injected i.v. over 2 min. Two patients, who needed supplementary doses of neuromuscular blocking drug because of the duration of the operation, received additional infusions of vecuronium. One patient received vecuronium 1.4 ug kg" 1 min" 1 for 44 min and the other 0.8 ug kg" 1 min" 1 for 50 min. The degree of neuromuscular blockade was assessed by recording the twitch height of the adductor pollicis muscle, which was indirectly stimulated by cutaneous electrodes placed over the ulnar nerve at the wrist. The ulnar nerve was stimulated by single electrical square wave impulses of 0.2 ms duration at a frequency of 0.1 Hz, generated by a Myotest nerve stimulator. The resulting twitch tension was measured by means of a Statham force displacement transducer and recorded on a Gould brush recorder. Registration of neuromuscular blockade was started after the induction of anaesthesia and the intubation of the trachea. The twitch height was then allowed to recover to the highest point possible and seen to maintain this height for 10 min before proceeding with the study.
Blood was sampled from a vein in the antecubital fossa of the arm contralateral to that to which vecuronium was injected. A plastic cannula with a three-way stop-cock was kept open by an infusion of lactated Ringer's solution and was used for sampling. A blood sample taken several minutes before the injection of vecuronium acted as a control (blank). Blood was sampled at the end of the injection and 1, 3, 5, 7, 10, 15, 30, 60, 90, 120, 180, 240 and 300 min after the injection. Eight millilitre of blood was withdrawn on each occasion and added to 2 ml of a 0.1-mol litre" 1 solution of NaH,PO 4 . This decreased the pH of blood to 5 and stopped the degradation of vecuroruum. The samples were sent to the laboratory and centrifuged. The supernatant serum was siphoned off and deep frozen to -30 °C to await further analysis. In 11 patients, 2-ml spot samples of bile were aspirated from the common bile duct by the surgeon, at the times after the injection of vecuronium shown in figure 3. The times of sampling were dictated by surgical requirements. One sample only was procured from six patients and two samples from four patients. Buffer was added to the samples until the pH was between 5 and 6, as denoted by pH-sensitive paper. The amount of buffer added was noted and the total amount of bile and buffer recorded. As with the blood samples, bile samples were then deep frozen to -30 °C to await further analysis.
Bile was collected from patients who underwent choledochotomy and had a T-tube inserted (n = 6). Collection of bile was commenced as soon as possible after the injection of vecuronium, but this was never feasible before the end of operation. Because of various surgical manipulations, these operations were exceptionally prolonged and no bile could be collected within 2-3 h of the injection of the vecuronium. Ten millilitre of the buffer was added to the empty bile bag in each case at the start of collection of bile. Bile was collected every 6 h for 24 h after the injection of vecuronium. At each collection the amount of bile in the bag was noted, 8 ml of bile was transferred to a test tube and the pH of this was adjusted to 5-6 by the addition of further buffer to the test tube. The amount of buffer added was recorded and the sample of bile sealed and deep frozen for further analysis.
Procedure: Part II
A small wedge-shaped biopsy was taken from the liver of patients, who underwent partial liver resection for localized hepatic tumours or cysts, several minutes after an i.v. injection of a dose of vecuronium (table II) . In spite of their liver disease, none of these patients had disturbed liver function.
The biopsy material was obtained from an area of the liver that was not clinically affected by the disease. The biopsies were weighed, submerged in a measured quantity of the buffer solution, immediately homogenized and the concentration of vecuronium and its metabolites in the homogenate measured as described below.
Chemical analysis
The concentrations of vecuronium in plasma, bile and liver homogenate were measured by a modification of the method used to measure the concentration of pancuronium (Kersten, Meijer and Agoston, 1973) . The aggregate amount of vecuronium and its deacetylated metabolites was first determined fluorimetrically after formation of ion-pair complexes of vecuronium or its metabolites with the fluorescent dye Rose Bengal. This method has a sensitivity of 5 ng ml~l. The relative quantities of vecuronium and each of its three putative metabolites (3-hydroxy, 17-hydroxy and 3,17-dihydroxy vecuronium) were then determined by separation with thin-layer chromatography, followed by visual comparison of spots of the separated compounds with the size and density of spots containing known amounts of reference compounds on the same plate. This semi-quantitative method has a coefficient of variation of ± 10% and as little as 150 ng of a compound can be detected.
Data analysis
Individual curves of the decrease in plasma concentration of vecuronium were fitted by a computerized program written by one of the authors (A.H.J.S.). This program can resolve the plasma curves into up to five exponential terms, using weighted, linear least-square regression of the experimental data plotted on a semi-logarithmic scale. The number of exponential terms which best fitted the plasma curves was determined by the criteria described by Boxenbaum, Riegelman and Elashoff (1974) . 
RESULTS

Neuromuscular blockade with vecuronium
Plasma concentration of vecuronium
None of the metabolites of vecuronium were found in the plasma of any of the 13 patients in part I of the study.
The decline of vecuronium plasma concentration in many of these patients showed large fluctuations ( fig. 2) . The plasma curve could be best resolved into two-exponential curves in 46% of the patients (n = 6) and into a three-exponential curve in the rest (n = 7). In view of these inconsistencies, further extensive, phannacokinetic analysis of these curves was not carried out.
Change of the concentration of vecuronium in the bile
This is shown in figure 3 , which is a composite plot made up of vecuronium concentration in the bile "spot" samples from 11 patients from part I of the study.
The concentration of vecuronium was extremely high, even in the samples taken about 20 min after the injection of the vecuronium, and was 30-50 times greater than that found in the plasma at the same time (compare figure 3 with figure 2 ). Unfortunately, no bile spot samples could be procured before 20 min and we do not know if vecuronium appears in bile earlier than 20 min after injection. Besides unchanged vecuronium, only the 3-hydroxy metabolite of vecuronium was found in two of these samples, at 29 and 44 min after injection, making up 3.1 and 4.8%, respectively, of the total fluorescently active compounds detected in these two samples.
Biliary excretion of vecuronium
The total biliary excretion of vecuronium (unchanged drug and metabolites) in six patients is summarized in table IV. At 24 h after injection, 11 % of the injected dose of vecuronium was found unchanged in the bile; 1.5% of the i.v. dose was recovered as the 3-hydroxy metabolite. Neither of the other two metabolites of vecuronium, namely the 17-hydroxy and the 3,17-dihydroxy, was found in the bile.
Content of vecuronium in liver biopsies
The amount of vecuronium found in the pieces of liver is shown in table II (second column from right). As can be seen from the last column on the right, and assuming an even distribution of vecuronium throughout the liver, the amount of vecuronium in these pieces of liver would represent a substantial amount of the administered dose of vecuronium 5 min after injection.
DISCUSSION
The duration and recovery index of vecuronium in the patients investigated in the present study were more prolonged than those recorded in other studies after a similar dose (150 ug kg" 1 ) of vecuronium (Fahey et al., 1981; Mirakhur et al., 1983; Bencini and Newton, 1984) . This could be ascribed in the first instance to the relatively high concentration of halothane used in this study, which is known to potentiate the effects of vecuronium (Foldes, Bencini and Newton, 1980; Engebaek, 0rding and Viby-Mogensen, 1983) . Although other workers (Fahey et al., 1981; Mirakhur et al., 1983 ) also used halothane for their studies on vecuronium, they used a smaller concentration (^ 1%) than we did.
Second, suxamethonium has been shown to potentiate the effect of vecuronium when injected before vecuronium (Krieg et al., 1980; Krieg, Hendriks and Crul, 1981; D'Hollander et al., 1983) . A third contributing factor, which might also explain the fluctuations in the decrease in the plasma concentration of vecuronium, is worthy of consideration. Operations on the biliary tract are often accompanied by considerable displacement of the liver and biliary tract as a result of traction, torsion, etc. Moreover, in our department surgical procedures such as manometry of the biliary tract and retrograde cholangiography, which can cause high intraluminal pressures in the bile ducts, are carried out routinely during surgery. It is possible that all these manoeuvres can lead to obstruction of bile flow. Although no data are available regarding acute peroperative alterations in bile secretion during these manoeuvres, extrahepatic cholestasis is known to cause prolongation of the elimination half-lives of neuromuscular blocking drugs, leading to a prolongation of their effects (Somogyi, Shanks and Triggs, 1977; Westra et al., 1980; Westra et al., 1981) . This mechanism might account for the small amount of vecuronium found in the bile of patient 1 in table IV.
The amount of vecuronium recovered in the bile in this study (12.5%) was probably grossly underestimated. The average amount of bile collected from each patient following operation, via the T-drains (table IV) , amounted to only one-third of that secreted on average by man (675 ml per day) (Davenport, 1966) . This lost volume of bile alone would increase the average percentage of the injected vecuronium excreted in the bile to about 40%. Moreover, bile sampling was begun at least 3h after the injection of vecuronium. Considering the high concentrations of vecuronium found in the bile during the first 3 h, quite sizeable amounts of vecuronium could have been additionally lost in this period. This agrees with our findings in investigations in animals in which 46% and 40% of vecuronium was found excreted in the bile of rats and cats (Bencini et al., 1985) , respectively. It appears from the present study that biliary excretion is the major pathway of elimination of (mostly unchanged) vecuronium in man also.
Vecuronium, like tubocurarine (Meijer et al., 1979) falls into the group of drugs excreted by the liver, with a high bile: plasma concentration ratio (Brauer, 1959) . Carrier-mediated transport processes are possibly involved in the uptake and excretion of this group of drugs by the liver. The large concentrations of vecuronium appearing in the bile 20 min after the injection of vecuronium, together with the apparently large amounts expected to be found in the liver at about 30 min after injection, coincide with the rapid recovery from the neuromuscular blockade produced by an intubating dose (100 ng kg" 1 ) of vecuronium Buzello et al., 1980; Fahey et al., 1981; Fragen et al., 1982; Gramstad Lilleaasen and Minsaas, 1983; Rupp, Miller and Gencarelli, 1984) . If vecuronium is taken up rapidly and to such a large extent by the liver as is suggested by this study, it is plausible that its short duration of action is chiefly attributable to its rapid hepatic uptake. In connection with this, we have shown, in other studies in cats, that the duration and recovery rate of vecuronium are prolonged significantly when the liver is isolated from the circulation after an i.v. injection (Bencini, Houwertjes and Agoston, 1985) .
In conclusion, this study provides evidence that more than 40% of vecuronium is excreted (mostly unchanged) in the bile after an i.v. injection. The hepatic uptake of vecuronium is rapid, and probably determines to a considerable extent the rapid decrease in the plasma concentration of vecuronium to less than effective concentrations. Major surgical manipulations of the liver and biliary tract, as occurred in the present study, could interfere with the hepatic distribution and clearance processes, and may in turn lead to a fluctuating decrease in the plasma concentration, with a consequent prolonged effect of neuromuscular blockade.
